CJC-1295 (with DAC, Drug Affinity Complex) is a modified GHRH analogue carrying an affinity complex that prolongs its circulating activity, studied in growth-hormone research. It is supplied as a high-purity white lyophilized powder, >=99% by HPLC, in sealed vials for laboratory use. The DAC modification extends the peptide's action, making it valuable for research on growth hormone release, neuroendocrine regulation and related metabolic pathways, and it is commonly applied in cell-based and preclinical studies. The lyophilized presentation provides excellent stability and reproducible reconstitution for consistent experimental dosing. Every batch is quality-controlled and batch-specific COA can be supplied on request. Unopened product should be kept sealed at 2-8 degree C away from light and moisture, with -20 degree C recommended for long-term storage. We accept both trial and bulk orders, and OEM and private-label service is available. This peptide is for laboratory research use only.